¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ&Á¦21Â÷ °ü»óµ¿¸Æ¿Ü°úÇÐȸ Çмú½ÉÆ÷Áö¿ò (2ÀÏÂ÷) : 2024-04-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ&Á¦21Â÷ °ü»óµ¿¸Æ¿Ü°úÇÐȸ Çмú½ÉÆ÷Áö¿ò (2ÀÏÂ÷) : 2024-04-12
±³À°ÀÏÀÚ : 2024-04-12
±³À°Àå¼Ò : ÀüÁÖ ¶óÇÑÈ£ÅÚ, ¿Â°íÀ»È¦(1F)

±³À°ÁÖÁ¦ : ´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ&Á¦21Â÷ °ü»óµ¿¸Æ¿Ü°úÇÐȸ Çмú½ÉÆ÷Áö¿ò (2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑÈäºÎ¿Ü°úÇÐȸ(21.11.10 ¸íĪº¯°æ ´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : °ü»óµ¿¸Æ¿Ü°úÇÐȸ

´ã´çÀÚ : ÇÑÈñ¼ö
¿¬¶ôó : 02-6002-1382

À̸ÞÀÏ : hhs@ghkh.co.kr

±³À°Á¾·ù : ÈäºÎ¿Ü°ú

Âü¼®¿¹»óÀÎ : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : Àü¶óºÏµµ
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 150,000¿ø  

ºñ°í "°ü»óµ¿¸Æ¿Ü°úÇÐȸ Á¤È¸¿ø : »çÀüµî·Ï ¹«·á / ÇöÀåµî·Ï 8¸¸¿ø Àü¹®ÀÇ : »çÀüµî·Ï 12¸¸¿ø/ ÇöÀå 15¸¸¿ø Àü°øÀÇ, °£È£»ç, ü¿Ü¼øȯ»ç , ±×¿Ü °ü°èÀÚ : »çÀü 8¸¸¿ø/ ÇöÀå 10¸¸¿ø Çлý : »çÀü ¹«·á/ ÇöÀå ¹«·á ´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ ¿ø·Îȸ¿ø: »çÀü ¹«·á/ ÇöÀå ¹«·á"


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 08:30~08:45 Overview and embryology of coronary artery anomaly ±èÀº³ª(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 08:45~09:00 Diagnostic tools and surgical indications of anomalous aortic origin of coronary artery ±¸º»±Ç(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 09:00~09:15 Surgical correction of anomalous aortic origin of coronary artery ¹Úõ¼ö(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 09:15~09:30 Indication and surgical correction of coronary arteriovenous fistula in the adults ±èÈñÁß(°í·ÁÀÇ´ë)

Åä·Ð 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 09:30~09:50 Discussion All Speakers()

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 09:50~10:30 Lifetime Achievement Award À¯°æÁ¾(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 11:00~11:20 1-y Results of CONFIG trial ¼Õ¼®È£(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 11:20~11:40 Outcomes of Coronary Arterial Bypass Surgery in Ischemic Cardiomyopathy According to the Number of Inflow Source ¹Ú¼ºÁØ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 11:40~12:00 IMPACT OF MORE THAN ONE DISTAL ANASTOMOSIS TO DISEASED CORONARY ARTERY TERRITORY ON LONG-TERM SURVIVAL Á¶ÇÑÀÌ(¼­¿ïÀÇ´ë)

Åä·Ð 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 12:00~12:20 Discussion All Speakers()

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 12:20~13:20 From the First Page : ½ÉÇ÷°üÁúȯ ¿¹¹æÀ» °í·ÁÇÑ ½ºÅ¸Æ¾ ¼±ÅÃÀÇ Á߿伺 ±è´ë¿ø(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 13:20~13:35 Myocardial protection during on-pump CABG ±è¿í¼º(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 13:35~13:50 Myocardial protection during off-pump CABG; when to shunt and when to snare ±èÁÖ¿¬(ÀÎõ¼¼Á¾º´¿ø)

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 13:50~14:05 Surgical considerations in reoperative CABG À±¿µ³²(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 14:05~14:20 Surgical considerations in ESRD patients undergoing CABG Á¶±¤¸®(ÇѶ󺴿ø)

Åä·Ð 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 14:20~14:40 Discussion All Speakers()

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 15:10~15:25 Bundles for opioid sparing pain management °í¿ø¿í(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 15:25~15:40 Eearly extubation and minimial sedation ÀÌ¿¹¿ø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 15:40~15:55 Screening and management of postoperative delirium Àü¼Ò¿¬(Ãæ³²ÀÇ´ë)

±³À°½Ã°£ 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 15:55~16:10 Introduction of commercial products for ERAS-Cardiac & wrap up Ȳȣ¿µ(¼­¿ïÀÇ´ë)

Åä·Ð 04¿ù 12ÀÏ ¿Â°íÀ»È¦(1F) 16:10~16:30 Discussion All Speakers()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ&Á¦21Â÷ °ü»óµ¿¸Æ¿Ü°úÇÐȸ Çмú½ÉÆ÷Áö¿ò (2ÀÏÂ÷) : 2024-04-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ(¸Á¸·ÀÇ ÃÖ½ÅÁö°ß) : 2024-04-12
´ÙÀ½±Û 2024³â ´ëÇѸ鿪ÇÐȸ 50Áֳ⠱â³ä Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2024-04-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
495 °­¿ø ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø NAFLD(non-alcoholic fatty liver disease) and Cardiometabolic Syndrome [7th Gangwon Heart Seminar 2018] : 2018-09-07 0 919 2018-08-22
494 ÀüºÏ ÀüÁÖ ¿¹¼öº´¿ø ´ëÇÑÀçÈ°ÀÇÇÐȸ È£³²Á¦ÁÖÁöȸ ÀçÈ° ½ÉÆ÷Áö¾ö : 2018-09-07 0 1,006 2018-08-22
493 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2018-09-07 0 793 2018-08-22
492 ¼­¿ï 2018³â °³¿øÀǸ¦ À§ÇÑ °­µ¿°æÈñ´ëÇб³º´¿ø ¼ÒÈ­±âÁúȯ ¿¬¼ö°­Á : 2018-09-06 0 617 2018-08-22
491 Ãæ³² ´Ü±¹´ëÇб³º´¿ø 2018³â Á¦3Â÷ ´ëÇѺ´¸®ÇÐȸ ´ëÀü¤ýÃæûÁöȸ: ÃÖ½ÅÀÇÇÐÁ¤º¸ Ư°­ ¹× º´¸®ÇÐ Áõ·Ê ¹ßÇ¥ : 2018-09-06 0 716 2018-08-22
490 ´ë±¸ ´ëÇѽŻý¾ÆÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2018-09-06 0 984 2018-08-22
489 Àü³² Á¦257Â÷ ´ëÇѳ»°úÇÐȸ ±¤ÁÖÀü³²Áöȸ Çмú´ëȸ : 2018-09-06 0 573 2018-08-22
488 °æ³² ´ëÇÑÇǺΰúÇÐȸ º£Ã¼Æ®º´ÀÇ ÃÖ½ÅÁö°ß¿¡ °üÇÏ¿© : 2018-09-06 0 678 2018-08-22
487 Ãæ³² °Ç¾ç´ëÇб³º´¿ø ´ëÇÑÇǺΰúÇÐȸ ÃæûÁöºÎÇÐȸ : 2018-09-06 0 865 2018-08-22
486 ´ë±¸ °è¸í´ëÇб³ µ¿»êÀÇ·á¿ø ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Á¦234Â÷ °æºÏÁöȸ Áý´ãȸ : 2018-09-06 0 730 2018-08-22
485 °æ±â °¡Å縯´ëÇб³ ºÎõ¼º¸ðº´¿ø ´ëÇѺñ´¢±â°úÇÐȸ 2018 Á¦ 3Â÷ ÀÎõ.°æ±âÁöȸ Áý´ãȸ : 2018-09-06 2 1,451 2018-08-22
484 °æ³² ´ëÇÑÈäºÎ¿Ü°úÇÐȸ 2018³âµµ 3Â÷ ºÎ»ê¿ï»ê°æ³² ÈäºÎ¿Ü°ú Áý´ãȸ ¹× °­¿¬ : 2018-09-06 0 686 2018-08-22
483 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú 2Çбâ Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-06 0 528 2018-08-22
482 ºÎ»ê ºÎ»ê±¤¿ª½ÃÀÇ»çȸ ¼­±¸ÀÇ»çȸ 9¿ù Çмúȸ : 2018-09-05 0 623 2018-08-22
481 ´ë±¸ 2018³â ´ëÇÑ°¨¿°ÇÐȸ ¿µ³²Áöȸ 9¿ù Áý´ãȸ : 2018-09-05 0 467 2018-08-22
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷